MDGL Stock Summary and Trading Ideas (Madrigal Pharmaceuticals | NASDAQ:MDGL)

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.

What symbol and exchange does Madrigal Pharmaceuticals shares trade?

Madrigal Pharmaceuticals trades on the NASDAQ stock market under the symbol MDGL.

What is Madrigal Pharmaceuticals stock price doing today?

As of March 31, 2026, MDGL stock price climbed to $523.47 with 491,784 million shares trading.

What is Madrigal Pharmaceuticals's Beta?

MDGL has a beta of 0.32, meaning it tends to be less sensitive to market movements. MDGL has a correlation of 0.02 to the broad based SPY ETF.

How much is Madrigal Pharmaceuticals worth?

MDGL has a market cap of $11.67 billion. This is considered a Large Cap stock.

How much money does Madrigal Pharmaceuticals make?

Last quarter Madrigal Pharmaceuticals reported $321 million in Revenue and -$2.57 earnings per share. This beat revenue expectation by $8 million and missed earnings estimates by -$2.05.

What is the highest and lowest price Madrigal Pharmaceuticals traded in the last 3 year period?

In the last 3 years, MDGL traded as high as $615.00 and as low as $119.76.

What are the top ETFs holding Madrigal Pharmaceuticals?

The top ETF exchange traded funds that MDGL belongs to (by Net Assets): VTI, IWM, VB, XBI, VXF.

Is Madrigal Pharmaceuticals (MDGL) a good investment?

MDGL has outperformed the market in the last year with a price return of +59.7% while the SPY ETF gained +18.4%. However, in the short term, MDGL had mixed performance relative to the market. It has underperformed in the last 3 months, returning -10.3% vs -5.1% return in SPY. But in the last 2 weeks, MDGL shares have fared better than the market returning +18.7% compared to SPY -2.5%.

What are the support and resistance levels for Madrigal Pharmaceuticals (MDGL)?

MDGL support price is $490.96 and resistance is $519.72 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MDGL shares will trade within this expected range on the day.